A good quarter despite tepid sales growth for Dr Lal PathLabs
Dr Lal Pathlabs, a leading diagnostic company has come up with its Q2 Results. We look at the results and management commentary in this post. ...
Like our content? Join Capitalmind Premium.
- Equity, fixed income, macro and personal finance research
- Model equity and fixed-income portfolios
- Exclusive apps, tutorials, and member community
Subscribe Now
Or start with a free-trial
Already a subscriber?
Login Now
Related Posts
Zen Tech: Spearheading Innovation in Defence
Are defense stocks losing their shine? Has the long-term growth trend reversed? We doubt it. While stocks in this sector were down anywhere between 20-35%, we ...
Which is the best REIT in India?
As the market anticipates a potential rate cut by RBI in the near future, InvITs & REITs as an asset class are well-positioned to benefit. With that in mind, ...
Which is the best InvIT in India?
Looks like InvITs have hit a bit of a rough patch recently. But hey, every cloud has a silver lining, right? Could this dip in price be a buying opportunity? ...